Answers are grounded in this paper and cite their sources.
Case report demonstrates successful mechanical and chemical pleurodesis for isolated pulmonary lymphangioleiomyomatosis, highlighting tailored surgical intervention without immediate sirolimus.
Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease characterized by abnormal smooth muscle proliferation, leading to cystic destruction of the lung parenchyma. We present the case of a female in her early 40s who presented with intermittent chest pain for 1 month. Imaging revealed left hydropneumothorax with multiple bilateral pulmonary parenchymal cysts, and a subsequent lung biopsy confirmed the diagnosis of pulmonary LAM. The patient underwent video-assisted thoracoscopic surgery (VATS) with mechanical and chemical pleurodesis. Given her stable condition, no immediate sirolimus therapy was initiated, and close follow-up with serial imaging was planned. This case highlights the diagnostic challenges of LAM, especially with low VEGF-D levels, and underscores the role of pleurodesis as a management option in select patients. Early recognition and tailored management are essential to optimize patient outcomes.
No takes yet. Share an insight, caveat, or question.
Shehzad et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: